Fadraciclib

Overview

Fadraciclib is an oral and intravenous CDK (cyclin-dependent kinase) inhibitor being studied for use in several different cancers.

SparkCures ID 546
Generic Name Fadraciclib
Treatment Classifications

Clinical Trials

Resources

There are no resources, links or videos to display for this treatment.